Fuse Biotherapeutics
Los Angeles, US · Founded 2021 · Delaware corporation
Find your way into Fuse Biotherapeutics
Sign up to see every warm intro you have to Fuse Biotherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Fuse Biotherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
YW
Yuanheng Wang LiangNamed on SEC filing
JT
Jeffrey TakimotoNamed on SEC filing
BR
Brian RabinovichNamed on SEC filing
PS
Paul SongNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$8.2M disclosed across 1 round · 2021
▶$8.2MraisedNov 2021 · 8 investors · PharmaceuticalsRule 506(b)
▶$8.2MraisedNov 2021 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Yuanheng Wang LiangDirector
- Jeffrey TakimotoExecutive Officer
- Brian RabinovichExecutive Officer, Director
- Paul SongExecutive Officer, Director
- Offering amount
- $9.6M
- Amount sold
- $8.2M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Fuse Biotherapeutics raised?
- Fuse Biotherapeutics has disclosed $8.2M raised across 1 round.
- Where is Fuse Biotherapeutics headquartered?
- Fuse Biotherapeutics is headquartered in Los Angeles, US.